Targeted therapies

BOSTON, Mass. and TOKYO, Japan, July 28, 2026 CORE Biomedicine has entered into an exclusive global licensing agreement with...

IRVING, Texas, May 15, 2026 Caris Life Sciences announced the publication of a new study in The Oncologist demonstrating...

ESSEN/MUNICH, Germany, September 9, 2025 – Evonik and Ethris have entered a strategic partnership to enhance RNA-based therapeutic solutions...

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has...